Luisa Bonilla retweeted
Congrats Ainhoa! 🎉👏Outstanding PhD brilliantly presented! It was a real pleasure and honour to co-direct your thesis! Looking forward to continue working together!
Very happy for defending my PhD today
⚪Grateful to my 🔝🔝 directors @StephanieLheur5 & @AnaOaknin and tutor @dvalcarcel
⚪Honoured to have @PerezFidal @CristinaSaura3 & @Esanzgarcia as an outstanding reviewer panel
Luisa Bonilla retweeted
📣 Do not miss this great e-Session on the newest data on DDR targeting agent @ESOncology
Join us for an insightful e-Session on "DNA damage response targeting agents" featuring expert Timothy Yap and Ilaria Colombo (@Ilaria_Colombo_) as discussant.
📅 Today, 18:15 CEST
Don't miss out ➡️ bit.ly/e-ESO
#ESOncology #oncology #oncologyeducation
Luisa Bonilla retweeted
Apply for the CRIS Cancer-Princess Margaret drug development fellowship @criscancer @pmcancercentre - great opportunity for those with interests in phase I trials and translational research criscancer.org/es/cris-princ…
Luisa Bonilla retweeted
Such an honor to be part of this great event! Thanks @myESMO for the opportunity.
The ESMO Summit Africa 2024 just wrapped up 📢 Three outstanding days together looking into 👇
✅ The most significant treatment advances presented at ESMO Congresses
✅ Current standard of care for key malignancies from local & international perspectives
ow.ly/CTBU50QAK5C
Luisa Bonilla retweeted
New germline genetic testing guidelines: All women with breast cancer diagnosis under the age of 65 should be offered germline genetic testing. They don’t need to meet any additional criteria. Thank you @ASCO for the opportunity to draft these guidelines.
ascopubs.org/doi/full/10.120…
Luisa Bonilla retweeted
One of the most important trials presented and published in 2023
🌟🌟🌟 In DESTINY-PanTumor02, Trastuzumab deruxtecan showed durable responses across HER2-expressing solid tumors ➡️ brnw.ch/21wFvEs #gyncsm #hpbcsm #blcsm @MDAndersonNews
Luisa Bonilla retweeted
Correct! Anthracyclines were originally discovered in Italy approximately 70 years ago by a company named Farmitalia.
A member of the team went on expedition to Castel del Monte, in Puglia, in which soil he identified a strain of Streptomyces producing a substance with antitumoral proprieties: he called it “Daunomycin”, from the tribes of “Daunii” that used to live in Puglia during the Bronze Age.
The first trials with daunomycin were conducted at the NCI of Milan and at MSKCC, describing the first clinical responses. Meanwhile, the team at Farmitalia kept working on the molecule, developing an even more potent analogue.
They called it “Adriamycin”, from the Adriatic Sea that bathes the shores of Puglia, and that can be easily reached from Castel del Monte, where everything started.
More info here: journals.sagepub.com/doi/10.…
Luisa Bonilla retweeted
Happy to present at #ESMO23 the results of #MBOT the first app 📱 for Ambulatory Malignant Bowel Obstruction management in #gynecancer @pmcancercentre
Thanks to @ConquerCancerFd for making it possible through a #YIA grant – at Madrid, Spain
Luisa Bonilla retweeted
I❤️❤️being a thoracic oncologist: while our GI colleagues still struggle with folfox and folfiri 🥱we have numerous new exciting ⚡️& effective Tx 🔥 ADCs will soon be a part of our new routine so register to this webinar by @IASLC with @danieltanmd Ben Levy and Toni Wozniak
Antibody drug conjugates are novel agents developed for the treatment of a variety of cancers, including #lungcancer. In 2 weeks, this webinar will describe the mechanism of action of these agents, their current use & areas of development. Register: bit.ly/emergingADCSinLC #LCSM
Luisa Bonilla retweeted
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in HER2+ #CRC
@NatureComms
doi.org/10.1038/s41467-023-3…
👉ORR 45.3%, mPFS 6.9, mOS 15.5 and DoR 7.0 mo in IHC 3+/IHC 2+,ISH+
👉Pneumonitis 9.3%, TEAEs ≥3 65%
👉sig. activity independent of prior 🎯💊
@myESMO @OncoAlert
Luisa Bonilla retweeted
I’m pretty certain I’m alive because I am white & was born into a middle class family in the US.
Dr Upal Basu Roy & I often say while I/everyone deserves quality care, it’s hard to balance when much of what we advocate for will only reach ppl like me ‘a person of privilege’ 😔
Dr Ji @WinshipAtEmory #ASCO23
🚨 New #Medicaid insurance after a #cancer diagnosis and non-continuous medicaid associated with ⬆️ mortality (HR >2) in children & AYA with blood cancers
Only 36% of Medicaid-insured children & AYA have continuous insurance coverage
Luisa Bonilla retweeted
Great work 👉Sonia trial showed first line CDK4/6 didn't improved survival vs 2nd line CDK4/6 with increased clinical and financial toxicity!
🎯 Urgent need for more studies focused on patient and health care sustainability!
Luisa Bonilla retweeted
🔥Lynch syndrome: a single hereditary cancer syndrome or multiple syndromes defined by different mismatch repair genes?
@AGA_Gastro
doi.org/10.1053/j.gastro.202…
🧐Interesting food for thoughts on tumor risk and carcinogenesis in #Coloncancer
@myESMO @OncoAlert
Luisa Bonilla retweeted
Really amazing data on GDC-6036 plus cetuximab in KRAS G12C metastatic colon cancer - ORR 62% !!! More potent KRAS G12C inhibitors make for more effective combos & better options for patients. #AACR23 @KRASKickers
Luisa Bonilla retweeted
Meet our #GuestEditors of the #2023SpecialIssue 🌟
Dr. Ainhoa Madariaga @AinhoaMada
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @agz_eriksson @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4
Luisa Bonilla retweeted
#ESMOGynae23:#CervicalCancer is a preventable disease so, although research advances are increasing treatment opportunities for all women diagnosed at any stage, we must stop it before it hits.
🔗 ow.ly/WlEH50N0ymn
Luisa Bonilla retweeted
Replying to @criscancer @pmcancercentre
Exciting 2-year clinical research fellowship opportunity at the Princess Margaret @pmcancercentre in Toronto with our phase I trials program, a new initiative co-supported by @criscancer
Luisa Bonilla retweeted
What an honor @EChrisDee ! @OphiraG is a superstar! Lets make #global #oncology access to care , equity, diversity, inclusion, capacity building , common sense ,and much more the hot topics for the next 20 years + 🤩🤩 @LancetRH_Americ @TheLancetOncol
@QueensGlobalOnc @QueensCRI – at Manhattan, NY
Thrilled to get to speak with #leaders in #global #oncology 🌎🌍🌏 Drs @OphiraG and @fabiomoraesmd 🤩
Happy 200th bday 🥳 @TheLancet and thank you @NYAMNYC for hosting 🙏
Onwards and upwards for global #health #equity 🚀














































